# A long-term culture model for investigating senescence-associated dysregulation in macrophages

**Authors:** Andy Ruiz, María Guadalupe Lucero-Gil, Martha Torres, Esmeralda Juárez

PMC · DOI: 10.3389/fimmu.2025.1661497 · Frontiers in Immunology · 2025-10-02

## TL;DR

This paper introduces a long-term lab model to study how aging affects macrophage function, showing they become less flexible and more inflammatory over time.

## Contribution

A reproducible in vitro model to study macrophage senescence and its impact on immune function over extended periods.

## Key findings

- Macrophages cultured for 14-21 days show increased senescence markers and reduced plasticity.
- Senescent macrophages shift from anti-inflammatory to proinflammatory profiles and restrict cytokine diversity.
- The model reveals dynamic macrophage subpopulations and functional changes linked to aging.

## Abstract

Macrophage senescence is increasingly recognized as a key contributor to immune dysfunction during aging and chronic inflammation. Here, we developed a reproducible long-term in vitro culture model to investigate the senescence’s phenotypic and functional consequences in human macrophages. Monocyte-derived macrophages (MDMs) were cultured for 7, 14, or 21 days and assessed for canonical senescence markers and immune function. While macrophages at day 7 exhibited minimal expression of β-galactosidase, H2AXpS139, and CDKN2A (p16INK4a), these markers were significantly upregulated at days 14 and 21, indicating progressive acquisition of a senescent phenotype. Cell viability remained above 95% across all time points, confirming the system’s stability. High-dimensional flow cytometry and unsupervised clustering revealed marked phenotypic remodeling over time, shifting from anti-inflammatory CD163+/CD206+ profiles to proinflammatory CD14+/CD64+/TLR2+ populations. Five distinct macrophage subpopulations were identified, each with dynamic temporal distribution and unique marker expression, highlighting a loss of plasticity and emergence of senescence-associated states. Functionally, day 7 macrophages produced a diverse cytokine panel responding to lipopolysaccharide (LPS), including IL-2, IL-12p70, IL-4, IL-5, TNF-α, GM-CSF, IFN-γ, and IL-10. In contrast, macrophages at days 14 and 21 displayed a markedly restricted cytokine profile, retaining the secretion of cytokines but significantly downregulating the secretion of Th1-type cytokines. This long-term culture model constitutes a robust, physiologically relevant tool to study immune aging, senescence-driven immune reprogramming, and inflammation in macrophages with the potential for the preclinical evaluation of therapeutic strategies to ameliorate inflammaging and restore immune competence.

## Linked entities

- **Genes:** CDKN2A (cyclin dependent kinase inhibitor 2A) [NCBI Gene 1029], CD163 (CD163 molecule) [NCBI Gene 9332], MRC1 (mannose receptor C-type 1) [NCBI Gene 4360], CD14 (CD14 molecule) [NCBI Gene 929], FCGR1A (Fc gamma receptor Ia) [NCBI Gene 2209], TLR2 (toll like receptor 2) [NCBI Gene 7097]
- **Proteins:** CDKN2A (cyclin dependent kinase inhibitor 2A)
- **Chemicals:** IL-2 (PubChem CID 51397006), IL-4 (PubChem CID 171905173), IL-5 (PubChem CID 57407714), IL-10 (PubChem CID 146070)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** GLB1 (galactosidase beta 1) [NCBI Gene 2720] {aka EBP, ELNR1, MPS4B}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, CD14 (CD14 molecule) [NCBI Gene 929], FCGR1A (Fc gamma receptor Ia) [NCBI Gene 2209] {aka CD64, CD64A, FCG1, FCGR1, FCRI, FcgammaRI}, CD163 (CD163 molecule) [NCBI Gene 9332] {aka M130, MM130, SCARI1}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, MRC1 (mannose receptor C-type 1) [NCBI Gene 4360] {aka CD206, CLEC13D, CLEC13DL, MMR, MRC1L1, bA541I19.1}, CDKN2A (cyclin dependent kinase inhibitor 2A) [NCBI Gene 1029] {aka ARF, CAI2, CDK4I, CDKN2, CMM2, INK4}, TLR2 (toll like receptor 2) [NCBI Gene 7097] {aka CD282, TIL4}, IL2 (interleukin 2) [NCBI Gene 3558] {aka IL-2, TCGF, lymphokine}, IL5 (interleukin 5) [NCBI Gene 3567] {aka EDF, IL-5, TRF}, CSF2 (colony stimulating factor 2) [NCBI Gene 1437] {aka CSF, GMCSF}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}
- **Diseases:** chronic inflammation (MESH:D007249), immune dysfunction (MESH:D007154)
- **Chemicals:** LPS (MESH:D008070)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12529554/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12529554/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC12529554/full.md

---
Source: https://tomesphere.com/paper/PMC12529554